"The Warriors - Fighting the Incurable Juvenile Huntington's Disease" is now available to watch for FREE at https://t.co/9jNB9fP4MK
#JuvenileHuntingtonsDisease
PROOF-HD update:
Participant enrollment has been completed ahead of schedule! We are so grateful to all the amazing participants, families, and the #HuntingtonsDisease community in helping to achieve this study milestone!
Full release: https://t.co/c2NlGfEayr
🚨🚨🚨👇
FAMILY DAY at HSG 2021 is just one month from today! Join us virtually on November 6.
It is FREE to attend but make sure you register in advance.
--> https://t.co/oeNAqPCJKW
#HSG2021#UnmaskingHD#Huntingtonsdisease#conference
FAMILY DAY at #HSG2021... You don't want to miss this! #UnmaskingHD#Huntingtonsdisease
Register today for FREE access to all the sessions and content on November 6!
https://t.co/oeNAqPl8mm
KINECT-HD2 is an open-label study of valbenazine for chorea in #HuntingtonsDisease. KINECT-HD2 is currently recruiting subjects in the United States and Canada to participate in the #clinicaltrial on study drug. To learn more, visit the study website – https://t.co/B5EdZR9CoX
14 blinded procedures have now been completed, with no significant safety concerns observed. We continue to be very pleased with the enrollment of this important study and look forward to having the trial fully enrolled by middle of next year." https://t.co/5B0GJWeuzT
JHD Initiative – Welcome To https://t.co/BDTusfD6aA Where You Can Read These Kids Stories And Learn More Families Alike The Juvenile Onest Of Huntington's Disease Sharing Personal Stories And Faces Of Kids For Awareness Helping Relating And Understanding https://t.co/6Cr2oF261Q
Neurofilament Light Protein (NfL) is emerging as a potential biomarker for Adult Onset Huntington's- researchers suggest the NfL may also play a role in JoHD and pre-manifest HD. https://t.co/feLPzPGTAj @LaurenByrne7337@Schultz_Lab@filipebrodrigue
Check out the following update from uniQure:
"Two more patient procedures have been completed in the higher-dose cohort in our #genetherapy trial of AMT-130 for #Huntingtonsdisease following a positive recommendation by the independent DSMB.
Meet Dr. Jordan Schultz, PharmD @Schultz_Lab! While heading up his own research lab, he's also a member of the Nopoulos Lab! Check out one of his most recent publications about CAG repeat length and cognitive performance in young adults. https://t.co/JWHF4erIfO
This article is amazing. What @BJsView says is so spot on: "I can’t keep looking down the hall and thinking, 'Well, those people are working on it.' I need to find new ways to get involved and creative ways to speed up this process.
https://t.co/u3u4RNuTcZ
A new system has been developed that allows researchers to fine-tune gene expression with oral drugs, work that provides a powerful tool for gene editing. https://t.co/6qSq2ztooE
KINECT-HD2 is actively recruiting 30 participants in the U.S. & Canada for an open-label study of valbenazine in #HuntingtonsDisease#chorea. Enrolled participants will receive the study drug, valbenazine. To learn more about the study, visit https://t.co/B5EdZR9CoX